Lóránt Gönczi

1.4k total citations · 1 hit paper
64 papers, 804 citations indexed

About

Lóránt Gönczi is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Lóránt Gönczi has authored 64 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Genetics, 40 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Lóránt Gönczi's work include Inflammatory Bowel Disease (53 papers), Microscopic Colitis (39 papers) and Biosimilars and Bioanalytical Methods (15 papers). Lóránt Gönczi is often cited by papers focused on Inflammatory Bowel Disease (53 papers), Microscopic Colitis (39 papers) and Biosimilars and Bioanalytical Methods (15 papers). Lóránt Gönczi collaborates with scholars based in Hungary, Canada and United States. Lóránt Gönczi's co-authors include Péter L. Lakatos, Johan Burisch, Mirabella Zhao, Talat Bessissow, Petra A. Golovics, Zsuzsanna Kürti, Waqqas Afif, Jason Reinglas, Barbara D. Lovász and Zsuzsanna Végh and has published in prestigious journals such as Gastroenterology, World Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Lóránt Gönczi

57 papers receiving 791 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Burden of Inflammatory Bowel Disease in Europe in 2020

2021 265 citations Lóránt Gönczi, Péter L. Lakatos et al. Journal of Crohn s and Colitis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lóránt Gönczi Hungary	14	557	415	220	149	89	64	804
Nikolas Plevris United Kingdom	14	528 0.9×	423 1.0×	234 1.1×	177 1.2×	42 0.5×	53	699
Paula Ministro Portugal	15	420 0.8×	333 0.8×	224 1.0×	93 0.6×	63 0.7×	58	647
Barbara D. Lovász Hungary	16	709 1.3×	605 1.5×	338 1.5×	119 0.8×	35 0.4×	46	890
Fábio Vieira Teixeira Brazil	14	432 0.8×	319 0.8×	265 1.2×	186 1.2×	37 0.4×	59	731
Hélène Sarter France	16	661 1.2×	583 1.4×	257 1.2×	86 0.6×	32 0.4×	49	831
Garrett Lawlor United States	15	436 0.8×	481 1.2×	207 0.9×	107 0.7×	114 1.3×	48	908
Gary R Lichtenstein United States	4	589 1.1×	504 1.2×	265 1.2×	93 0.6×	39 0.4×	9	792
K T Park United States	8	427 0.8×	282 0.7×	164 0.7×	76 0.5×	49 0.6×	12	610
Adérson Omar Mourão Cintra Damião Brazil	16	447 0.8×	341 0.8×	271 1.2×	114 0.8×	76 0.9×	62	833
Petra A. Golovics Hungary	19	917 1.6×	763 1.8×	399 1.8×	196 1.3×	51 0.6×	78	1.1k

Countries citing papers authored by Lóránt Gönczi

Since Specialization

Citations

This map shows the geographic impact of Lóránt Gönczi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lóránt Gönczi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lóránt Gönczi more than expected).

Fields of papers citing papers by Lóránt Gönczi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lóránt Gönczi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lóránt Gönczi. The network helps show where Lóránt Gönczi may publish in the future.

Co-authorship network of co-authors of Lóránt Gönczi

This figure shows the co-authorship network connecting the top 25 collaborators of Lóránt Gönczi. A scholar is included among the top collaborators of Lóránt Gönczi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lóránt Gönczi. Lóránt Gönczi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gönczi, Lóránt, et al.. (2025). Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management. Expert Opinion on Biological Therapy. 25(9). 967–978. 1 indexed citations

Gönczi, Lóránt, Petra A. Golovics, Tünde Pandúr, et al.. (2025). Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort. World Journal of Gastroenterology. 31(33). 109800–109800.

Kürti, Zsuzsanna, et al.. (2023). Objective Disease Monitoring Strategies from a Tertiary Inflammatory Bowel Disease Center in Hungary. The Turkish Journal of Gastroenterology. 34(5). 508–515. 2 indexed citations

Lakatos, Péter L., et al.. (2023). OP09 Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras – Results from a Western Hungarian Population-based Inception Cohort between 1977–2020. Journal of Crohn s and Colitis. 17(Supplement_1). i14–i16. 1 indexed citations

Wetwittayakhlang, Panu, Lóránt Gönczi, Petra A. Golovics, et al.. (2023). Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977–2020. Journal of Clinical Medicine. 12(8). 3026–3026. 5 indexed citations

Wetwittayakhlang, Panu, et al.. (2023). Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977–2020. Clinical Gastroenterology and Hepatology. 22(1). 191–193.e3. 6 indexed citations

Wetwittayakhlang, Panu, Petra A. Golovics, Lóránt Gönczi, et al.. (2023). P829 The Burden of Colorectal Cancer in Patients with Ulcerative Colitis – Incidence and Risk factors from a Population-based Inception Cohort from Veszprem county, Western Hungary, from 1977–2020. Journal of Crohn s and Colitis. 17(Supplement_1). i961–i962. 1 indexed citations

Gönczi, Lóránt, Klaudia Farkas, Tamás Molnár, et al.. (2022). Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study. Digestive and Liver Disease. 54(12). 1639–1645. 10 indexed citations

Golovics, Petra A., Lóránt Gönczi, Christine Verdon, et al.. (2021). P364 Patient reported outcomes, partial MAYO score and SCCAI are equally accurate in predicting mucosal healing in UC: final results form a prospective study. Journal of Crohn s and Colitis. 15(Supplement_1). S381–S382.

10.

Gönczi, Lóránt, Zsuzsanna Kürti, Isabelle Morin, et al.. (2020). Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes. World Journal of Gastroenterology. 26(7). 759–769. 10 indexed citations

11.

Khoury, Alex Al, Zsuzsanna Kürti, Lóránt Gönczi, et al.. (2020). The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center. Journal of Gastrointestinal and Liver Diseases. 29(4). 555–559. 5 indexed citations

12.

Rencz, Fanni, Peep F. M. Stalmeier, Márta Péntek, et al.. (2019). Patient and general population values for luminal and perianal fistulising Crohn’s disease health states. The European Journal of Health Economics. 20(S1). 91–100. 6 indexed citations

13.

Reinglas, Jason, Lóránt Gönczi, Christine Verdon, et al.. (2019). Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center. Digestive Diseases and Sciences. 65(7). 2046–2053. 12 indexed citations

14.

Gönczi, Lóránt, Talat Bessissow, & Péter L. Lakatos. (2019). Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?. World Journal of Gastroenterology. 25(41). 6172–6189. 32 indexed citations

15.

Kürti, Zsuzsanna, Ákos Iliás, Lóránt Gönczi, et al.. (2018). Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database. BMC Gastroenterology. 18(1). 23–23. 4 indexed citations

16.

Iliás, Ákos, et al.. (2018). Biosimilars in ulcerative colitis: When and for who?. Best Practice & Research Clinical Gastroenterology. 32-33. 35–42. 5 indexed citations

17.

Gönczi, Lóránt, et al.. (2018). Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?. World Journal of Gastroenterology. 24(22). 2363–2372. 20 indexed citations

18.

Reinglas, Jason, et al.. (2018). Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases. World Journal of Gastroenterology. 24(32). 3567–3582. 32 indexed citations

19.

Gönczi, Lóránt, Zsuzsanna Kürti, Petra A. Golovics, et al.. (2017). Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies. Digestive and Liver Disease. 50(1). 37–41. 10 indexed citations

20.

Gönczi, Lóránt, Zsuzsanna Kürti, Mariann Rutka, et al.. (2017). Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases. BMC Gastroenterology. 17(1). 97–97. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact